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T he skin covers the entire external surface of the body and maintains the body’s homeostasis.  The 
skin not only forms an effective barrier against various 
forms of environmental damage and microbial invasion,  
but also maintains moisture and biochemical metabo-
lism.  Following injury,  skin wound healing is rapidly 
initiated and occurs efficiently in several phases: he-
mostasis,  inflammation,  granulation tissue formation,  
re-epithelialization,  neovascularization,  and remodel-
ing [1 , 2].  Re-epithelialization is an important step in 
repairing damaged skin,  and is accomplished by the 
migration,  proliferation,  and differentiation of kerati-
nocytes.  Keratinocytes migrate on the fibrinogen/
fibrin-rich and fibronectin-rich provisional extracellu-
lar matrix (ECM),  followed by a newly forming der-
mal-epidermal junction through the concerted action of 
epidermal and dermal cells [3 , 4].
The basement membrane (BM) is a sheet-like ECM 
found beneath epithelial cells and surrounding blood 
vessels and muscle cells.  The BM is composed of colla-
gen IV,  laminin,  nidogen,  perlecan and other glyco-
Acta Med.  Okayama,  2019
Vol.  73,  No.  2,  pp.  135-146
CopyrightⒸ 2019 by Okayama University Medical School.
http ://escholarship.lib.okayama-u.ac.jp/amo/Original Article
Collagen XVIII Deposition in the Basement Membrane Zone beneath the  
Newly Forming Epidermis during Wound Healing in Mice
Takahiro Maebaa,  Tomoko Yonezawaa＊,  Mitsuaki Onoa,  Yasuko Tomonob,   
Ritva Heljasvaarac,d,  Taina Pihlajaniemic,  Kiichi Inagawae,  and Toshitaka Oohashia
aDepartment of Molecular Biology and Biochemistry,  Okayama University Graduate School of Medicine,   
Dentistry and Pharmaceutical Science,  Okayama 700-8558,  Japan,  bShigei Medical Research Institute,   
Okayama 701-0202,  Japan,  cOulu Center for Cell-Matrix Research,  Biocenter Oulu,   
Faculty of Biochemistry and Molecular Medicine,  University of Oulu,  Oulu FIN-90014,  Finland,   
dCenter for Cancer Biomarkers CCBIO,  Department of Biomedicine,  University of Bergen,  Bergen N-5009,  Norway,   
eDepartment of Plastic and Reconstructive Surgery,  Kawasaki Medical School,  Kurashiki,  Okayama 701-0192,  Japan
The basement membrane (BM) is composed of various extracellular molecules and regulates tissue regeneration 
and maintenance.  Here,  we demonstrate that collagen XVIII was spatiotemporally expressed in the BM during 
skin wound healing in a mouse excisional wound-splinting model.  Re-epithelialization was detected at days 3 
and 6 post-wounding.  The ultrastructure of epidermal BM was discontinuous at day 3,  whereas on day 6 a con-
tinuous BM was observed in the region proximal to the wound edge.  Immunohistochemistry demonstrated that 
collagen XVIII was deposited in the BM zone beneath newly forming epidermis in day 3 and 6 wounds.  
Laminin-332,  known to be the earliest BM component appearing in wounds,  was colocalized with collagen 
XVIII in the epidermal BM zone at days 3 and 6.  The deposition of α1(IV) collagen and nidogen-1 in the epi-
dermal BM zone occurred later than that of collagen XVIII.  We also observed the short isoform of collagen 
XVIII in the epidermal BM zone at day 3 post-wounding.  Collectively,  our results suggested that collagen 
XVIII plays a role in the formation of the dermal-epidermal junction during re-epithelialization,  and that it is 
the short isoform that is involved in the early phase of re-epithelialization.
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proteins.  It provides mechanical support,  separates 
tissue into different compartments,  serves as a selective 
molecular sieve,  and influences cell phenotypes,  
including cellular proliferation,  migration,  differentia-
tion,  and death [5 , 6].
Collagen IV comprises six α chains,  i.e.,  α1 (IV) to 
α6 (IV),  and three molecular forms have been identi-
fied: α1α2α1 (IV),  α3α4α5 (IV) and α5α6α5 (IV).  The 
α1 (IV),  α2 (IV),  α5 (IV) and α6 (IV) chains are pres-
ent in the epidermal BM [7 , 8].  Collagen IV molecules 
form mesh-like networks,  providing a molecular scaf-
fold for interactions between other BM components to 
form a mature BM.  These scaffolds provide structural 
support for nearby cells [9-11].  Laminins are major 
components of the BM and form heterotrimeric mole-
cules in a tissue-specific manner.  For example,  lami-
nin-511 and laminin-521 are preferentially expressed in 
the epidermal BM.  Laminin-332 is an essential compo-
nent of the dermal-epidermal junction that acts as an 
anchoring filament; it is expressed immediately post-
wound to promote keratinocyte adhesion and migration 
[4 , 12-14].  Mutations in the LAMA3,  LAMB3 and 
LAMC2 genes cause junctional epidermolysis bullosa,  
which is characterized by skin fragility and mechani-
cally induced blistering [15 , 16].  Both perlecan and 
nidogen bridge the scaffolds formed by laminin and 
collagen IV [17-19].
In addition to these major components,  collagen 
XVIII,  which is a heparan sulfate proteoglycan,  is 
known to exist widely in various BMs.  It is structurally 
characterized by a collagenous triple-helical domain 
with multiple interruptions flanked by an N-terminal 
thrombospondin domain and a C-terminal endostatin 
(ES) domain,  and by glycosaminoglycan side chains.  
The gene encoding collagen XVIII is known to generate 
three distinct variants: the short,  medium and long 
isoforms.  Recent studies have demonstrated that these 
three isoforms differ in tissue distribution and functions 
(for review see [20]).  Two alternative promoters drive 
the expression of the short transcript or the long tran-
script,  and the latter is alternatively spliced to generate 
the medium isoform [21-24].  The three isoforms have 
N-terminal non-collagenous (NC) domains of different 
lengths,  but their collagenous and C-terminal NC 
domains are identical.  The C-terminal NC-1 domain 
includes ES,  which has been found to have anti-angio-
genetic and anti-tumorigenic activities [25].  The short 
collagen XVIII isoform is the predominant form in epi-
thelial and endothelial BMs,  and the longer isoforms 
are produced particularly in the liver and kidney glom-
eruli [26-28].  In humans,  mutations in the COL18A1 
gene result in Knobloch syndrome,  which is character-
ized by severe ocular abnormalities and occipital skull 
defects,  and sometimes result in other manifestations 
such as renal abnormalities and hypertriglyceridemia 
[20].  Collagen XVIII-deficient (Col18a1−/−) mice display 
severe eye abnormalities like those reported in 
Knobloch patients [29-32].  The characterization of 
isoform-specific mutant mice lacking expression of the 
short isoform has revealed that the absence of the short 
isoform is sufficient to cause the eye defects found in 
Knobloch patients [33].  Mice lacking the medium and 
long isoforms display hypertriglyceridemia mediated by 
the impairment of adipocyte maturation and a decrease 
in the number of adipocytes [28].
In regard to the distribution of collagen XVIII in 
human skin,  it has been demonstrated that the short 
and medium and/or long isoforms are present in the 
epidermal BM,  and only the short isoform is present in 
the BMs surrounding blood vessels and muscle cells 
[27].  In situ hybridization further showed that collagen 
XVIII mRNA was expressed in keratinocytes of the epi-
dermis in human adult and fetal skin [27].  However,  
the expression pattern and function of each isoform of 
collagen XVIII in skin wound healing are unknown.
Seppinen et al.  reported that skin wound healing was 
delayed in ES-transgenic (tg) mice but accelerated in 
Col18a1−/− mice; however,  there was no difference in 
the re-epithelialization rate at day 3 post-wound 
between the Col18a1−/− or ES-tg mice and the control 
mice [34].  The faster wound healing in the Col18a1−/− 
mice was attributed to an increased number of con-
tracting myofibroblasts in the knockout wounds [34].  
The vascularization rate of the granulation tissue was 
unaltered in ES-tg mice but was more rapid in the 
Col18a1−/− mice [34].  The presence of excess ES affected 
the structure and formation of epidermal and vascular 
BMs in skin wound healing [34].
Collagen XVIII exhibits a polarized orientation in 
BMs underlying the epidermis and retinal pigment epi-
thelial cells,  and in the kidney glomerular BM [24 , 26].  
The binding activity of the C-terminal NC-1 domain to 
perlecan and other BM components appears to play a 
structural role.  Interestingly,  Col18a1−/− and ES-tg mice 
display widening of the lamina densa of the epidermal 
BM in electron microscopy [26 , 35-37].  The expression 
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of collagen XVIII and the binding of its C-terminal 
NC-1 domain to perlecan and other BM components 
thus appear to be important for the integrity of BMs.
The use of rodents to assess the processes of skin 
wound healing has frequently been criticized because of 
the rapid wound contraction.  In the present study,  we 
used the so-called splinting model of skin wound heal-
ing to evaluate the deposition of collagen XVIII and 
other ECM components in the epidermal BM.  This 
model better mimics the wound healing in humans,  as 
it has a proper excisional defect size to assess the re- 
epithelialization process and uses a silicone splint to 
minimize the rate of wound contraction [38].  We thus 
used this wound-splinting model to explore the role of 
collagen XVIII in the epidermal BM.  Herein we 
describe the spatiotemporal expression of collagen 
XVIII isoforms in the dermal-epidermal junction in the 
splinting model,  which may provide insights into the 
roles of this collagen in wound healing.
Materials and Methods
Animal experiments. Eight-week-old C57BL/6J 
mice were purchased from CLEA Japan (Tokyo).  All 
animal experiments were performed in accord with the 
approved protocols and guidelines of the Animal 
Research Committee at Okayama University (OKU-
2015427 and -2017051).  The wound model was estab-
lished as described by Galiano et al.  [38].  In brief,  
full-thickness defects,  including those of panniculus 
muscle,  were made using an 8-mm biopsy punch (Kai 
Industries,  Seki,  Gifu,  Japan) in the dorsal skin of the 
mouse after hair removal under anesthesia with oxygen 
and 2% isoflurane inhalation (Pfizer,  New York,  NY,  
USA).  A splint made from a 1-mm-thick silicone sheet 
was fixed to the skin using Aron Alpha® (Toagosei,  
Tokyo) and 5-0 nylon sutures,  and the wounds were 
covered with IV3000 (Smith & Nephew,  London,  UK) 
as an occlusive dressing.  Wound tissues were harvested 
at days 3 , 6 and 9 post-wounding.  Three mice were 
used for each time point of each experiment.
Histological study. Tissues were embedded in 
Tissue-Tek® O.C.T.  compound (Sakura Finetek Japan,  
Tokyo) and snap-frozen in liquid nitrogen.  Cryo-
sections (8-μm-thick) were fixed with 4% paraformal-
dehyde for 15 min and stained with hematoxylin and 
eosin (HE).  For immunohistochemistry,  cryosections 
(8-μm-thick) were fixed in acetone for 20 min at room 
temperature and were blocked in phosphate-buffered 
saline (PBS) with 1% bovine serum albumin (Sigma,  St. 
Louis,  MO,  USA) for 3 h at room temperature.  Before 
blocking,  specimens for collagen IV staining were 
treated with 6 M urea in 0.1 M glycine (pH 3.5) for 
10 min and incubated in 2 N HCl at 37°C for 10 min to 
expose the epitopes,  as described previously [39].
The sections were incubated with the primary anti-
bodies at 4°C overnight.  After washing,  the specimens 
were incubated with secondary antibodies for 40 min at 
room temperature,  and nuclei were stained with 
Hoechst 33258 (Polysciences,  Warrington,  PA,  USA).  
All images were taken with a BZ-700 microscope 
equipped with a BZ analyzer (Keyence,  Osaka,  Japan) 
and measured by ImageJ software (U.S.  National 
Institutes of Health,  Bethesda,  MD,  USA) for the anal-
ysis of re-epithelialized length,  wound length,  and 
immunopositive length in the sections of the central 
wound area.  The re-epithelialized length was defined as 
the length of epithelial growth from the wound edge,  
and the wound length was defined as the length 
between the wound edges.
Transmission electron microscopy (TEM). Wound 
tissues harvested on days 3 and 6 were fixed with 2% 
glutaraldehyde and 2% paraformaldehyde in phosphate 
buffer at 4°C overnight.  Specimens were postfixed with 
2% osmium tetroxide in 0.1 M phosphate buffer for 1.5 h 
at 4°C.  After dehydration with ethanol,  the specimens 
were embedded in Spurr resin (Polysciences) and cut in 
ultrathin sections (LEICA EM UC7; Leica Mikro-
systeme,  Vienna,  Austria).  The ultrathin sections were 
stained with uranyl acetate and lead citrate and exam-
ined using a transmission electron microscope 
(H-7650; Hitachi,  Tokyo) at the Central Research 
Laboratory,  Okayama University Medical School.
Antibodies. A rat monoclonal antibody,  CM186,  
against the NC1 domain of mouse collagen XVIII was 
used [40].  CM186 reacts with all three isoforms of 
mouse collagen XVIII.  Other primary antibodies were 
used as follows: rat monoclonal antibody H11 against 
α1(IV) collagen [41-43],  rat monoclonal antibody 
against perlecan (A7L6; Merck Millipore,  Burlington,  
MA,  USA),  rabbit polyclonal antibody Q36.4 specific to 
the medium and long collagen XVIII isoforms 
(Medium/Long-18) [28],  rabbit polyclonal antibody 
against laminin-332 (Immundiagnostik,  Bensheim,  
Germany),  rabbit polyclonal antibody against 
nidogen-1 kindly provided by Dr. T. Sasaki (Oita 
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University) and rabbit monoclonal antibody against 
cytokeratin 14 (abcam,  Cambridge,  UK).  The follow-
ing were used as secondary antibodies in the immuno-
histochemistry: Alexa Fluor 488 conjugated-donkey 
anti-rat IgG (Life Technologies,  Carlsbad,  CA,  USA) 
and Alexa Fluor 594 conjugated-donkey anti-rabbit IgG 
(Life Technologies).  A negative control was established 
by immunostaining with only the secondary antibodies 
(data not shown).
Quantitative real-time PCR (RT-qPCR). The 
wound samples were homogenized using a bead beat-
er-type homogenizer (μT-01; Taitec,  Saitama,  Japan) 
with 3-mm stainless beads (Taitec).  Following homog-
enization,  total RNA was extracted and purified by 
QIAzol® Lysis Reagent and an RNeasy® Mini Kit 
(Qiagen,  Hilden,  Germany),  and the cDNAs were syn-
thesized with ReverTra Ace reverse transcriptase 
(Toyobo,  Osaka,  Japan).  A real-time quantitative poly-
merase chain reaction (RT-qPCR) was performed with 
KAPA SYBR FAST qPCR Master Mix (Kapa Biosystems,  
Wilmington,  MA,  USA) and the StepOnePlusTM Real-
Time PCR system (Applied Biosystems,  Waltham,  MA,  
USA).  The relative RNA levels were calculated by the 
2ΔΔCt method.  Values were normalized to Gapdh expres-
sion.
The primer sequences were as follows: the short 
isoform of Col18a1,  5’-GGATGTGCTCACCAGTTT 
GG-3’ and 5’-GTCATCGATTTGTGAGATCTTC-3’;  
the medium isoform of Col18a1,  5’-CCAGACTTCCC 
AGAGAATGTTG-3’ and 5’-CCGGACATGAAACAG 
CAGC-3’; the long isoform of Col18a1,  5’-AGGAGG 
ACGGGTACTGTGTG-3’ and 5’-TGAGGGTCATCG 
ATTTGTGA-3’; Gapdh,  5’-ACAGCAACTCCCACT 
CTTCC-3’ and 5’-TCCACCACCCTGTTGCTGTA- 3’.
Statistical analysis. The results are presented as 
the mean ± standard deviation (SD).  All statistical anal-
yses were performed using Student’s unpaired t-tests 
and the IBM® SPSS® statistics ver. 20 software (IBM,  
Armonk,  NY,  USA).  P-values < 0.05 were considered 
significant.
Results
Wound morphology in full-thickness skin wound 
healing in mice. To validate our skin wound healing 
model in mice,  we observed the morphology of 
full-thickness wounds at days 3 , 6 and 9 post-wound-
ing.  The length of the re-epithelialization region and the 
wound length were determined in HE-stained sections.  
The sections from the central wound area were used for 
the analysis.  Wounds gradually decreased in size and by 
day 9 were approximately 50% of the size of the day 0 
wound (Fig. 1A , B).  The re-epithelialization length 
increased gradually and reached > 50% of the wound at 
day 6 (Fig. 1A , C).  At day 9,  re-epithelialization was 
complete (Fig. 1A , C).
To examine the ultrastructure of epidermal BM in 
the wounds at days 3 and 6,  we performed TEM.  We 
found a discontinuous lamina densa in the wound area 
at day 3,  specifically formed only beneath hemidesmo-
somes (Fig. 1D).  By contrast,  a continuous lamina 
densa,  which was linked with the lamina densa in the 
unwounded region,  was detected in the region proxi-
mal to the wound edge at day 6.  In the region distal to 
the wound edge at day 6,  a discontinuous lamina densa 
was detected,  as observed on day 3.  Hemidesmosomes 
were also observed along the entire epidermal basal 
layer on day 3 and 6,  except at the leading edge of the 
epidermis in wound tissue (data not shown).
Most of the hemidesmosomes in the wound were of 
an immature form (Fig. 1D).  In the region distal to the 
wound edge of the day 3 and day 6 wounds,  fibrin 
matrix was frequently observed under the newly formed 
epidermis as an electron-dense fibril-like structure 
(Fig. 1D,  distal).  The ultrastructure of the dermal- 
epidermal junction under the newly formed epidermis 
displayed BM formation with a different level of matu-
ration between day 3 and day 6 wounds.  We therefore 
used day 3 and day 6 wound tissues to investigate the 
expression of BM proteins during re-epithelialization in 
skin wound healing.
Collagen XVIII deposited in the dermal-epidermal 
junction during re-epithelialization. We performed 
immunohistochemistry to examine the distribution of 
BM proteins during re-epithelialization using day 3 and 
day 6 wounds.  Collagen XVIII was detected in epider-
mal and blood vessel BMs in unwounded skin 
(Fig. 2A , D: All-18).  At days 3 and 6,  the newly form-
ing cytokeratin 14-immunopositive epidermis was 
detected in the wound (Fig. 2G , H).  Collagen XVIII was 
deposited in the newly formed epidermal BM zone at 
days 3 and 6 (Fig. 2G , H).  Laminin-332 was deposited 
and completely colocalized with collagen XVIII in the 
epidermal BM zone at days 3 and 6 (Fig. 2A-F).
We next used immunohistochemistry to compare the 
spatiotemporal expressions of both collagen XVIII and 
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laminin-332 to those of collagen IV,  nidogen-1 and 
perlecan,  which are known typical components of the 
epidermal BM (Figs. 3 , 4).  We also determined the 
length of these proteins’ immunopositive signals in the 
newly formed epidermal BM zone in the wound (Fig. 5).  
Because the lengths of the immunopositive signals of 
collagen XVIII and laminin-332 were identical in the 
wound during re-epithelialization,  we assessed the dis-
tribution and length of collagen IV,  nidogen-1,  and 
perlecan by double immunostaining with either colla-
gen XVIII or laminin-332.
Neither α1 (IV) collagen nor nidogen-1 was detected 
in the newly formed epidermal BM zone at day 3 
(Fig. 3A-F).  At day 6,  α1 (IV) collagen and nidogen-1 
were detected in the newly formed epidermal BM zone 
(Fig. 4A-F),  but their lengths (76.78 ± 23.93% and 
74.13 ± 22.01%,  respectively),  although slightly shorter 
than that of laminin-332/collagen XVIII,  were not sig-
nificantly different (p = 0.384 and 0.268,  respectively) 
(n = 3) (Fig. 5).  Perlecan was expressed in the newly 
formed BM zone at days 3 and 6 (with the respective 
lengths of 76.60 ± 18.02% and 91.59 ± 6.49%); both of 
these lengths were slightly but not significantly shorter 
than that of laminin-332 (Fig. 3G-I , 4G-I; p = 0.374 and 
0.832,  respectively) (n = 3) (Fig. 5).
Distinct expression patterns depending on the col-
lagen XVIII isoform in re-epithelialization. The 
short,  medium,  and long isoforms of collagen XVIII 
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Fig. 1　 Histological analysis of full-thickness skin wounds in mice.  A,  Hematoxylin and eosin (HE) staining of sections from the central 
region of each wound at days 3 ,6 and 9.  Re-epithelialization was completed at day 9.  Dashed lines indicate re-epithelialization in the 
wound area.  Scale bars＝500 μm; B,  Wound length measured on HE-stained sections.  The length of the day 0 wound was 8 mm.  The 
wound length became gradually shorter.  Values are mean±SD (all n＝3); C,  The relative length of re-epithelialization was measured on 
HE-stained sections.  This length gradually increased,  and the day 9 wounds were completely re-epithelialized.  Values are mean±SD (all 
n＝3); D,  Ultrastructure of the dermal-epidermal junction of the proximal and distal regions to the wound edge at days 3 and 6.  The lam-
ina densa (arrowheads) was discontinuous in both the proximal and distal regions at day 3.  By contrast,  the lamina densa was discontin-
uous in the distal region but was restored in the region proximal to the wound edge at day 6.  Fibrin (＊) was observed under the basal 
epidermis in the region distal to the wound edge.  Arrows indicate hemidesmosomes.  Scale bars＝5 μm.
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Fig. 2　 Collagen XVIII expression during re-epithelialization.  Distribution of collagen XVIII (All-18: antibody that reacts with all collagen 
XVIII isoforms,  green) (A ,C ,D ,F ,G ,H),  laminin-332 (LM332,  red) (B ,C ,E ,F) and cytokeratin 14 (CK14,  red) (G ,H) at days 3 
(A-C ,G) and 6 (D-F ,H) post-wounding.  Merged images are shown in C ,F ,G and H.  Nuclei were counterstained with Hoechst 33258 
(blue) (G ,H).  Collagen XVIII and laminin-332 were colocalized beneath cytokeratin 14-immunopositive epidermis in the wound at days 3 
and 6.  The edges of the immunopositive signal of collagen XVIII (arrows),  laminin-332 (arrowheads) and cytokeratin 14 (open arrow︲
heads) are indicated.  Dashed lines: The wound border,  to the right side of which is the wound region.  Scale bars＝200 μm.
appear to have distinct functions in the human body 
[20].  We used immunohistochemistry to investigate 
which isoform(s) were associated with the promotion of 
epidermal BM formation after skin wounding.  In 
unwounded skin,  we detected an immunopositive sig-
nal using the antibody against the medium/long iso-
forms in the epidermal BM but not in blood-vessel BM 
(Fig. 6B, E).  During wound healing,  the deposition of 
the medium/long isoforms was not detected in the 
newly formed epidermal BM zone on day 3 (Fig. 6A-C).
By contrast,  deposition of the medium/long iso-
forms was detected in the newly formed epidermal BM 
zone of day 6 wounds,  but the length was shorter than 
that of the antibody against all isoforms,  including the 
short isoform of collagen XVIII (All-18) (Fig. 6D-F).  
The relative lengths of the medium/long isoforms at 
days 3 (16.21 ± 12.74%) and 6 (53.93 ± 8.05%) were sig-
nificantly shorter than that of All-18 on both days 
(p = 0.032 and 0.023,  respectively) (n = 3) (Fig. 6A-G).  
Thus,  our results demonstrated that the short isoform 
was the earliest isoform to appear in the newly forming 
epidermal BM zone during re-epithelialization.
We also compared the mRNA expression of each 
collagen XVIII isoform in day 3 wounds with that of 
day 0 wounds by real time RT-PCR.  The relative 
mRNA expression level of the short isoform was 
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Fig. 3　 Comparison of the expression of epidermal BM proteins in a day 3 wound.  Distributions of α1(IV) collagen (α1(IV),  green) 
(A ,C),  laminin-332 (LM332,  red) (B ,C ,H , I),  nidogen-1 (red) (E ,F),  perlecan (green) (G , I) and collagen XVIII (All-18: the antibody 
reacts with all collagen XVIII isoforms,  green) (D ,F) analyzed by immunohistochemistry.  Merged images are shown in C ,F and I.  Nuclei 
were counterstained with Hoechst 33258 (blue).  Collagen XVIII,  laminin-332 and perlecan were detected in the newly formed dermal-epi-
dermal junction at day 3,  but α1(IV) collagen and nidogen-1 were not found at this time point.  Arrows: The edge of the immunopositive 
signal of α1(IV) collagen (A ,C),  nidogen-1 (E ,F) or perlecan (G , I).  Arrowheads: the edge of the immunopositive signal of laminin-332 
(B ,C ,H , I) or collagen XVIII (D ,F).  Dashed lines: The wound border,  to the right side of which is the wound region.  Scale bars＝200
μm.
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Fig. 4　 Comparison of the expressions of epidermal BM proteins in day 6 wounds.  Distribution of α1(IV) collagen (α1(IV),  green) (A ,C),  
laminin-332 (LM332,  red) (B ,C ,H , I),  nidogen-1 (red) (E ,F),  perlecan (green) (G , I) and collagen XVIII (All-18: the antibody reacts with 
all collagen XVIII isoforms,  green) (D ,F) analyzed by immunohistochemistry.  Merged images are shown in C ,F and I.  Nuclei were coun-
terstained with Hoechst 33258 (blue).  Higher magniﬁcation of the area around the edge of the re-epithelialized epidermis in the boxes is 
shown in the respective insets.  α1(IV) collagen,  nidogen-1 and perlecan were detected in the newly formed dermal-epidermal junction.  
Arrows: The edge of the immunopositive signal of α1(IV) collagen (A ,C),  nidogen-1 (E ,F) or perlecan (G , I).  Arrowheads: The edge of 
the immunopositive signal of laminin-332 (B ,C ,H , I) or collagen XVIII (D ,F).  Dashed lines indicate the wound border,  to the right side 
of which is the wound region.  Scale bars＝200 μm.
R
el
at
iv
e 
le
ng
th
 o
f 
ex
tra
ce
llu
la
r 
m
at
rix
 c
om
po
ne
nt
s 
(%
)
0
20
40
60
80
100
day 6day 3
All-18 / Laminin-332
α1(IV) collagen
Nidogen-1
Perlecan
＊＊
＊＊
Fig. 5　 Diﬀerential expression of BM pro-
teins in the dermal-epidermal junction 
post-wounding.  The relative length of the 
immunopositive signal in the dermal-epidermal 
junction in day 3 and day 6 wounds is indi-
cated.  Values are mean±SD (all n＝3).  ＊＊
p＜0.001.
April 2019 Collagen XVIII in Skin Wound Healing 143
day 3
day 6
G
All-18D E Medium/Long-18 F
day 6 day 3 
R
el
at
iv
e 
le
ng
th
 t
o 
di
ﬀe
re
nc
e
in
 is
of
or
m
s 
(%
)
0
20
40
60
80
100
All-18 
Medium/Long-18
＊＊
All-18A Medium/Long-18 B C All-18 / Medium/Long-18 / Hoechst
200µm
R
el
. m
R
N
A
 le
ve
ls
day 3 day 0    
Short
R
el
. m
R
N
A
 le
ve
ls
day 3day 0   
Medium
R
el
. m
R
N
A
 le
ve
ls
day 3day 0  
Long
H
All-18 / Medium/Long-18 / Hoechst
0
1
2
3
4
5
0
1
2
3
4
5
0
1
2
3
4
5
Fig. 6　 Distinct expression patterns of the diﬀerent collagen XVIII isoforms during re-epithelialization.  The distributions of collagen XVIII 
(All-18: the antibody reacts with all collagen XVIII isoforms,  green) (A ,D) and the medium/long isoforms of collagen XVIII (Medium/Long-
18,  red) (B ,E) were analyzed by immunohistochemistry in day 3 (A-C) and 6 (D-F) wounds.  Sections were double-immunostained,  and 
the merged images are shown in C and F.  Nuclei were counterstained with Hoechst 33258 (blue).  Arrows: The edge of the immunopos-
itive signal of the medium/long isoforms.  Arrowheads: The edge of the immunopositive signal of collagen XVIII (All-18).  Dashed 
lines: The wound border,  to the right side of which is the wound region.  Scale bars＝200 μm.  G,  The relative length of the immunopos-
itive signal in the dermal-epidermal junction in the wound.  Values are mean±SD (all n＝3).  ＊p＜0.05; H,  The mRNA expressions of the 
short,  medium,  and long isoforms in day 0 and day 3 wounds were analyzed by real-time RT-PCR.  The most increased isoform in day 3 
wounds was the short form.  There were no signiﬁcant diﬀerences in the mRNA expression of all of the isoforms between day 0 and day 3 
wounds.  Values are mean±SD (all n＝3).
increased at day 3 to 3.25 ± 1.46 (Fig. 6H),  but this was 
not significantly greater than the value at day 0 
(p = 0.095).  Regarding the limited increase of the rela-
tive mRNA expression of the medium and long iso-
forms in day 3 wounds to 0.93 ± 0.56 and 1.43 ± 0.77,  
respectively,  these values were not significantly different 
from the day 0 wound values (p = 0.872 and 0.480,  
respectively) (n = 3) (Fig. 6H).
Discussion
Collagen XVIII is a component of epidermal and 
blood-vessel BMs in skin.  In the present study,  we 
investigated the collagen XVIII expression in skin 
wound healing in mice.  The results demonstrated that 
collagen XVIII was deposited in the BM zone under the 
newly forming epidermis during re-epithelialization.  
Collagen XVIII may participate as one of the earliest 
BM molecules in the formation of the dermal-epider-
mal junction in skin wound healing.
Time-dependent expression patterns of several ECM 
components and related molecules (including integrin) 
have been observed during BM formation in skin 
equivalents by co-cultured keratinocytes and fibroblasts 
[44-47] and during skin wound healing in vivo [48 , 49].  
Laminin-332 is known to be expressed in the wound 
area prior to the other components of the BM,  includ-
ing collagen IV,  perlecan and nidogen [12 , 13 , 45-50].  
We noted that collagen XVIII was deposited in the epi-
dermal BM zone at the same rate as migrating keratino-
cytes in the early wound healing phase,  and the colla-
gen XVIII expression spatiotemporally corresponded to 
that of laminin-332 (Fig. 2).  Our findings also showed 
that the short collagen XVIII isoform was the earliest 
form deposited beneath the newly forming epidermis,  
and that the medium/ long isoforms were deposited 
later (Fig. 6A-G).  The short isoform mRNA expression 
tended to be increased at day 3 post-wounding,  but the 
medium and long isoform mRNA expressions were both 
minimally changed (Fig. 6H).
Interestingly,  our TEM observations indicated that 
the lamina densa was discontinuously formed beneath 
the immature hemidesmosomes in day 3 wounds,  and 
then became continuous and appeared normal in the 
region proximal to the wound edge at day 6 (Fig. 1).  
The observed sequential ultrastructural changes of the 
BM agreed with those seen in a cell-culture model of 
epidermal cells on a collagen gel [51].  Collagen IV is 
known to be a major component of the lamina densa 
[18].  The results of our immunohistochemistry exam-
inations showed that the collagen IV and nidogen-1 
deposition in the BM zone were substantially delayed 
compared to those of laminin-332 and collagen XVIII 
(Figs. 3-5).  It is likely that the appearance of a continu-
ous lamina densa,  namely a mature BM,  corresponds 
to the depositions of collagen IV and nidogen-1 that we 
observed in the BM zone.  Taken together,  our findings 
indicate that (1) collagen XVIII was deposited in the BM 
zone identically to laminin-332 before the formation of 
a mature BM during re-epithelialization,  and (2) the 
short isoform was most closely associated with the early 
events of re-epithelialization.
Perlecan,  characterized as the most common hepa-
ran sulfate proteoglycan of BMs,  was deposited in the 
epidermal BM zone earlier than collagen IV and 
nidogen-1 (Figs. 3-5).  Heparan sulfate chains are asso-
ciated with the multifunction ability of perlecan to bind 
various ECM molecules,  cytokines and growth factors.  
Glycosaminoglycan side chains of collagen XVIII can 
mediate binding to BMs and form a growth-factor gra-
dient [20 , 52 , 53].  Collagen XVIII and perlecan may 
collaborate by supplying glycosaminoglycan chains 
prior to the formation of a BM scaffold of collagen IV in 
re-epithelialization.
The formation of the dermal-epidermal junction is 
critical for repairing damaged skin.  Because of the 
abnormality of the BM ultrastructure in several tissues 
of Col18a1−/− and ES-tg mice,  collagen XVIII is thought 
to be important for the integrity of BMs.  The binding 
activity of the NC-1 domain of collagen XVIII with 
other ECM components and integrins as receptors 
could be associated with the structural function 
[20 , 36].  During re-epithelialization,  the leading edge 
of the epidermis migrates over the fibrinogen/fibrin-
rich and fibronectin-rich provisional matrix [4].  The 
interaction between collagen XVIII and fibrinogen has 
been established [54],  and it was demonstrated that the 
fibrin deposition in injured liver was altered in 
Col18a1−/− mice [55].  The deposition of collagen XVIII 
under the migrating epidermis may promote the inter-
action between the epidermis and provisional matrix in 
the wound.
The C-terminal ES domain of the short isoform is 
normally directed at the plasma membrane whereas the 
N-terminus is oriented toward the fibrillary matrix in 
BMs in several tissues,  including epidermal BM 
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[20 , 29 , 35].  The short and medium/long collagen 
XVIII isoforms are expressed in the glomerular base-
ment membrane (GBM),  which is present between 
endothelial cells and podocytes,  and the C-terminal 
regions of all isoforms are embedded in the GBM [26].  
The polarized presence of collagen XVIII in the BM is 
believed to be important in maintaining BM integrity 
and for its physiological functions.  Our present results 
demonstrated that the short and medium/long isoforms 
are present in the epidermal BM during wound healing 
(Fig . 6).  However,  the isoform-specific functions and 
orientation in epidermal BM have not yet been identi-
fied.  The dynamic construction of basement mem-
branes depending on the phase and condition of skin 
wound healing is considered to be crucial for repairing 
damaged skin.  Our results suggest that collagen XVIII 
plays a role in the formation of the dermal-epidermal 
junction during re-epithelialization.
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